ArticleImmunologic research2016

Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.

Ricardo García-Muñoz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.